I don't necessarily believe the email from Laurel Hill is accurate. It's obviously a form letter, but it may be what they send out for every pending proxy and not specific to AMBS. I'm sure there is a review by the SEC but AMBS may have also simply decided to postpone it again.
(1)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links